Main Article Content



Dengue is a tropical disease which is a major cause of preventable mortality. It is essential to identify people who are at risk for progression to dengue hemorrhagic fever and dengue shock syndrome. Hence the search for an optimal biomarker which can identify patients at risk of progression to severe dengue is on. Some studies have indicated hypolipidemia to be a marker for the identification of critically ill patients. This study intended to find out the relationship between fasting lipid profile and dengue mortality and morbidity.


This was a comparative cross-sectional study conducted for 1 year at a Government hospital setup with a sample size of 132.


Out of the 132 patients, all patients had bleeding manifestations ranging from purpuric rashes to melena. 92 patients had capillary leak syndrome and 52 patients developed shock. Most of the patients who developed bleeding manifestations, capillary leakage and shock were found to have hypocholestrolemia and HDL<50mg/dl.


It can be concluded that serum fasting lipid profile is an easily accessible and affordable indicator for early identification of patients at risk of progression to severe dengue.

Article Details

How to Cite
Rajalakshmi Kandasamy Venkatraju, Boopathy Rajan Padmanabhan, & Bathragiri Marasamy. (2023). Fasting Lipid Profile as a Predictor of Mortality and Morbidity in Dengue Hemorrhagic Fever. Journal of Evolution of Medical and Dental Sciences, 12(7), 225–229.


  1. WHO Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva, Switzerland: World Health Organization 2009.
  2. Chakravarti A, Arora R, Luxemburger C. Fifty years of dengue in India. Trans R Soc Trop Med Hyg 2012;106(5):273-82.
  3. Thomas L, Broustey Y, Najioullah F, et al. Predictors of severe manifestations in a cohort of adult dengue patients. J ClinVirol 2010;48(2):96-9.
  4. Thanachartwet V, Oer-Areemitr N, Chamnanchanunt S, et al. Identification of clinical factors associated with severe dengue among Thai adults: a prospective study. BMC Infect Dis 2015;15:420.
  5. Povoa TF, Alves AM, Oliveira CA, et al. The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One 2014;9(4):e83386.
  6. Durán A, Carrero R, Parra B, et al. Association of lipid profile alterations with severe forms of dengue in humans. Arch Virol 2015;160(7):1687-92.
  7. Suvarna JC, Rane PP. Serum lipid profile: a predictor of clinical outcome in dengue infection. Trop Med Int Health 2009;14(5):576-85.
  8. Marin-Palma D, Sirois CM, Urcuqui-Inchima S, et al. Inflammatory status and severity of disease in dengue patients are associated with lipoprotein alterations. PLoS One 2019;14(3):e0214245.
  9. Tongluan N, Ramphan S, Wintachai P, et al. Involvement of fatty acid synthase in dengue virus infection. Virol J 2017;14(1):28.
  10. Hofer F, Gruenberger M, Kowalski H, et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor group common cold virus. Proc Natl Acad Sci USA 1994;91(5):1839-42.
  11. Feingold KR, Grunfeld C. Lipids: a key player in the battle between the host and microorganisms. J Lipid Res 2012;53(12):2487-248.
  12. Rothwell C, Lebreton A, Young NC, et al., Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 2009;389(1-2):8-19.
  13. Sehrawat P, Biswas A, Kumar P, et al. Role of cytokines as molecular marker of dengue severity. Mediterranean J Hematol Infect Dis 2018;10(1):e2018023.
  14. Heaton NS, Randall G. Multifaceted roles for lipids in viral infection. Trends Microbiol 2011;19(7):368-75.
  15. Grunfeld C, Feingold KR. Regulation of lipid metabolism by cytokines during host defense. Nutrition 1996;12:S24-6.